SciSparc : MitoCareX Update - Form 6-K -March 13, 2024 at 09:09 am EDT
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer ...
Source: marketscreener.com
📰 Alon Silberman News
Alon Silberman News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alon Silberman. Real-time updates on events, politics, business and more.
SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure -March 12, 2024 at 08:15 am EDT
MitoCareX Bio dedicates efforts to creating a predictive AI model to predict small molecules more efficiently TEL AVIV, Israel, March 12, 2024 -- SciSparc Ltd. , a specialty clinical-stage...
Source: marketscreener.com
SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure
MitoCareX Bio dedicates efforts to creating a predictive AI model to predict small molecules more efficiently TEL AVIV, Israel, March 12, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced that MitoCareX Bio Ltd. ("MitoCareX "), the Company’s venture with Dr. Alon Silberman t...
Source: yahoo.com
SciSparc: MitoCareX Reveals Promising Results with
MitoCareX Bio dedicates efforts to creating a predictive AI model to predict small molecules more efficiently TEL AVIV, Israel, March 12, 2024 (GLOBE...
Source: globenewswire.com
SciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery Platform
MitoCareX Bio met its second milestone as part of its joint venture agreement with the Company TEL AVIV, Israel, Dec. 13, 2023 -- SciSparc Ltd. , a specialty clinical-stage pharmaceutical...
Source: marketscreener.com
SciSparc Shares Surge 22% on Joint Venture's Positive Results
By Denny Jacob SciSparc shares shot up 22% to $5.99 on news that its joint venture focused on developing drugs for cancer treatments achieved positive...
Source: marketwatch.com
SciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery Platform
MitoCareX Bio has met its second milestone as part of its joint venture agreement with the Company TEL AVIV, Israel, Nov. 27, 2023 -- SciSparc Ltd. , a specialty clinical-stage...
Source: marketscreener.com
SCISPARC : INTERIM CONSOLIDATED FINANCIAL STATEMENTS - Form 6-K -October 16, 2023 at 05:06 pm EDT
SCISPARC LTD. INTERIM CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2023 UNAUDITED INDEX ...
Source: marketscreener.com